MediWound (MDWD) and USANA Health Sciences (USNA) Head-To-Head Survey

MediWound (NASDAQ: MDWD) and USANA Health Sciences (NYSE:USNA) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, dividends, analyst recommendations, valuation, profitability and earnings.


How to Become a New Pot Stock Millionaire

This table compares MediWound and USANA Health Sciences’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
MediWound -887.38% -234.12% -38.22%
USANA Health Sciences 5.97% 27.08% 19.75%

Valuation and Earnings

This table compares MediWound and USANA Health Sciences’ gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
MediWound $2.50 million 58.43 -$22.14 million ($0.62) -8.71
USANA Health Sciences $1.05 billion 2.14 $62.53 million $4.06 22.98

USANA Health Sciences has higher revenue and earnings than MediWound. MediWound is trading at a lower price-to-earnings ratio than USANA Health Sciences, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

MediWound has a beta of -0.19, indicating that its share price is 119% less volatile than the S&P 500. Comparatively, USANA Health Sciences has a beta of 0.82, indicating that its share price is 18% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent ratings and target prices for MediWound and USANA Health Sciences, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MediWound 0 0 6 0 3.00
USANA Health Sciences 0 1 1 0 2.50

MediWound currently has a consensus price target of $9.83, indicating a potential upside of 82.10%. USANA Health Sciences has a consensus price target of $95.00, indicating a potential upside of 1.82%. Given MediWound’s stronger consensus rating and higher probable upside, analysts clearly believe MediWound is more favorable than USANA Health Sciences.

Institutional and Insider Ownership

32.9% of MediWound shares are owned by institutional investors. Comparatively, 48.2% of USANA Health Sciences shares are owned by institutional investors. 53.2% of USANA Health Sciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.


USANA Health Sciences beats MediWound on 9 of the 13 factors compared between the two stocks.

About MediWound

MediWound Ltd., an integrated biopharmaceutical company, focuses on developing, manufacturing, and commercializing novel therapeutics products to address unmet needs. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns in the European Union, Israel, and Argentina. The company also develops EscharEx, which is in Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds. MediWound Ltd. was founded in 2000 and is headquartered in Yavne, Israel.

About USANA Health Sciences

USANA Health Sciences, Inc. develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia. Its product lines include USANA Nutritionals Essentials, Optimizers, Foods, Sense-beautiful science and All Other. Its USANA Nutritionals Essentials product line includes vitamin and mineral supplements that provide a foundation of total body nutrition for every age group beginning with children of approximately one year. Its Optimizers product line consists of targeted supplements designed to meet individual health and nutritional needs. Its Sense-beautiful science product line includes science-based, personal care products that support skin and hair by providing topical nourishment, moisturization and protection.

Receive News & Ratings for MediWound Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediWound and related companies with's FREE daily email newsletter.

Leave a Reply